Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis: Results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort)

Arnold J. Greenspon, Jordan M. Prutkin, Muhammad R. Sohail, Holenarasipur R. Vikram, Larry M. Baddour, Stephan B. Danik, James Peacock, Carlos Falces, Jose M. Miro, Elisabeth Blank, Christoph Naber, Roger Carrillo, Chi Hong Tseng, Daniel Z. Uslan

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Objectives: The purpose of this study was to determine whether the timing of the most recent cardiac implantable electronic device (CIED) procedure, either a permanent pacemaker or implantable cardioverter-defibrillator, influences the clinical presentation and outcome of lead-associated endocarditis (LAE). Background: The CIED infection rate has increased at a time of increased device use. LAE is associated with significant morbidity and mortality. Methods: The clinical presentation and course of LAE were evaluated by the MEDIC (Multicenter Electrophysiologic Device Cohort) registry, an international registry enrolling patients with CIED infection. Consecutive LAE patients enrolled in the Multicenter Electrophysiologic Device Cohort registry between January 2009 and May 2011 were analyzed. The clinical features and outcomes of 2 groups were compared based on the time from the most recent CIED procedure (early, <6 months; late, >6 months). Results: The Multicenter Electrophysiologic Device Cohort registry entered 145 patients with LAE (early = 43, late = 102). Early LAE patients presented with signs and symptoms of local pocket infection, whereas a remote source of bacteremia was present in 38% of patients with late LAE but only 8% of early LAE (p < 0.01). Staphylococcal species were the most frequent pathogens in both early and late LAE. Treatment consisted of removal of all hardware and intravenous administration of antibiotics. In-hospital mortality was low (early = 7%, late = 6%). Conclusions: The clinical presentation of LAE is influenced by the time from the most recent CIED procedure. Although clinical manifestations of pocket infection are present in the majority of patients with early LAE, late LAE should be considered in any CIED patient who presents with fever, bloodstream infection, or signs of sepsis, even if the device pocket appears uninfected. Prompt recognition and management may improve outcomes.

Original languageEnglish
Pages (from-to)681-687
Number of pages7
JournalJournal of the American College of Cardiology
Volume59
Issue number7
DOIs
StatePublished - Feb 14 2012

Fingerprint

Endocarditis
Equipment and Supplies
Infection
Registries
Lead
Implantable Defibrillators
Bacteremia
Hospital Mortality
Intravenous Administration
Signs and Symptoms
Sepsis
Fever
Anti-Bacterial Agents
Morbidity
Mortality

Keywords

  • endocarditis
  • implantable cardioverter-defibrillator
  • permanent pacemaker

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis : Results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). / Greenspon, Arnold J.; Prutkin, Jordan M.; Sohail, Muhammad R.; Vikram, Holenarasipur R.; Baddour, Larry M.; Danik, Stephan B.; Peacock, James; Falces, Carlos; Miro, Jose M.; Blank, Elisabeth; Naber, Christoph; Carrillo, Roger; Tseng, Chi Hong; Uslan, Daniel Z.

In: Journal of the American College of Cardiology, Vol. 59, No. 7, 14.02.2012, p. 681-687.

Research output: Contribution to journalArticle

Greenspon, AJ, Prutkin, JM, Sohail, MR, Vikram, HR, Baddour, LM, Danik, SB, Peacock, J, Falces, C, Miro, JM, Blank, E, Naber, C, Carrillo, R, Tseng, CH & Uslan, DZ 2012, 'Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis: Results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort)', Journal of the American College of Cardiology, vol. 59, no. 7, pp. 681-687. https://doi.org/10.1016/j.jacc.2011.11.011
Greenspon, Arnold J. ; Prutkin, Jordan M. ; Sohail, Muhammad R. ; Vikram, Holenarasipur R. ; Baddour, Larry M. ; Danik, Stephan B. ; Peacock, James ; Falces, Carlos ; Miro, Jose M. ; Blank, Elisabeth ; Naber, Christoph ; Carrillo, Roger ; Tseng, Chi Hong ; Uslan, Daniel Z. / Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis : Results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). In: Journal of the American College of Cardiology. 2012 ; Vol. 59, No. 7. pp. 681-687.
@article{9360e6c36dff45a780eb1177311bcf06,
title = "Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis: Results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort)",
abstract = "Objectives: The purpose of this study was to determine whether the timing of the most recent cardiac implantable electronic device (CIED) procedure, either a permanent pacemaker or implantable cardioverter-defibrillator, influences the clinical presentation and outcome of lead-associated endocarditis (LAE). Background: The CIED infection rate has increased at a time of increased device use. LAE is associated with significant morbidity and mortality. Methods: The clinical presentation and course of LAE were evaluated by the MEDIC (Multicenter Electrophysiologic Device Cohort) registry, an international registry enrolling patients with CIED infection. Consecutive LAE patients enrolled in the Multicenter Electrophysiologic Device Cohort registry between January 2009 and May 2011 were analyzed. The clinical features and outcomes of 2 groups were compared based on the time from the most recent CIED procedure (early, <6 months; late, >6 months). Results: The Multicenter Electrophysiologic Device Cohort registry entered 145 patients with LAE (early = 43, late = 102). Early LAE patients presented with signs and symptoms of local pocket infection, whereas a remote source of bacteremia was present in 38{\%} of patients with late LAE but only 8{\%} of early LAE (p < 0.01). Staphylococcal species were the most frequent pathogens in both early and late LAE. Treatment consisted of removal of all hardware and intravenous administration of antibiotics. In-hospital mortality was low (early = 7{\%}, late = 6{\%}). Conclusions: The clinical presentation of LAE is influenced by the time from the most recent CIED procedure. Although clinical manifestations of pocket infection are present in the majority of patients with early LAE, late LAE should be considered in any CIED patient who presents with fever, bloodstream infection, or signs of sepsis, even if the device pocket appears uninfected. Prompt recognition and management may improve outcomes.",
keywords = "endocarditis, implantable cardioverter-defibrillator, permanent pacemaker",
author = "Greenspon, {Arnold J.} and Prutkin, {Jordan M.} and Sohail, {Muhammad R.} and Vikram, {Holenarasipur R.} and Baddour, {Larry M.} and Danik, {Stephan B.} and James Peacock and Carlos Falces and Miro, {Jose M.} and Elisabeth Blank and Christoph Naber and Roger Carrillo and Tseng, {Chi Hong} and Uslan, {Daniel Z.}",
year = "2012",
month = "2",
day = "14",
doi = "10.1016/j.jacc.2011.11.011",
language = "English",
volume = "59",
pages = "681--687",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "7",

}

TY - JOUR

T1 - Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis

T2 - Results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort)

AU - Greenspon, Arnold J.

AU - Prutkin, Jordan M.

AU - Sohail, Muhammad R.

AU - Vikram, Holenarasipur R.

AU - Baddour, Larry M.

AU - Danik, Stephan B.

AU - Peacock, James

AU - Falces, Carlos

AU - Miro, Jose M.

AU - Blank, Elisabeth

AU - Naber, Christoph

AU - Carrillo, Roger

AU - Tseng, Chi Hong

AU - Uslan, Daniel Z.

PY - 2012/2/14

Y1 - 2012/2/14

N2 - Objectives: The purpose of this study was to determine whether the timing of the most recent cardiac implantable electronic device (CIED) procedure, either a permanent pacemaker or implantable cardioverter-defibrillator, influences the clinical presentation and outcome of lead-associated endocarditis (LAE). Background: The CIED infection rate has increased at a time of increased device use. LAE is associated with significant morbidity and mortality. Methods: The clinical presentation and course of LAE were evaluated by the MEDIC (Multicenter Electrophysiologic Device Cohort) registry, an international registry enrolling patients with CIED infection. Consecutive LAE patients enrolled in the Multicenter Electrophysiologic Device Cohort registry between January 2009 and May 2011 were analyzed. The clinical features and outcomes of 2 groups were compared based on the time from the most recent CIED procedure (early, <6 months; late, >6 months). Results: The Multicenter Electrophysiologic Device Cohort registry entered 145 patients with LAE (early = 43, late = 102). Early LAE patients presented with signs and symptoms of local pocket infection, whereas a remote source of bacteremia was present in 38% of patients with late LAE but only 8% of early LAE (p < 0.01). Staphylococcal species were the most frequent pathogens in both early and late LAE. Treatment consisted of removal of all hardware and intravenous administration of antibiotics. In-hospital mortality was low (early = 7%, late = 6%). Conclusions: The clinical presentation of LAE is influenced by the time from the most recent CIED procedure. Although clinical manifestations of pocket infection are present in the majority of patients with early LAE, late LAE should be considered in any CIED patient who presents with fever, bloodstream infection, or signs of sepsis, even if the device pocket appears uninfected. Prompt recognition and management may improve outcomes.

AB - Objectives: The purpose of this study was to determine whether the timing of the most recent cardiac implantable electronic device (CIED) procedure, either a permanent pacemaker or implantable cardioverter-defibrillator, influences the clinical presentation and outcome of lead-associated endocarditis (LAE). Background: The CIED infection rate has increased at a time of increased device use. LAE is associated with significant morbidity and mortality. Methods: The clinical presentation and course of LAE were evaluated by the MEDIC (Multicenter Electrophysiologic Device Cohort) registry, an international registry enrolling patients with CIED infection. Consecutive LAE patients enrolled in the Multicenter Electrophysiologic Device Cohort registry between January 2009 and May 2011 were analyzed. The clinical features and outcomes of 2 groups were compared based on the time from the most recent CIED procedure (early, <6 months; late, >6 months). Results: The Multicenter Electrophysiologic Device Cohort registry entered 145 patients with LAE (early = 43, late = 102). Early LAE patients presented with signs and symptoms of local pocket infection, whereas a remote source of bacteremia was present in 38% of patients with late LAE but only 8% of early LAE (p < 0.01). Staphylococcal species were the most frequent pathogens in both early and late LAE. Treatment consisted of removal of all hardware and intravenous administration of antibiotics. In-hospital mortality was low (early = 7%, late = 6%). Conclusions: The clinical presentation of LAE is influenced by the time from the most recent CIED procedure. Although clinical manifestations of pocket infection are present in the majority of patients with early LAE, late LAE should be considered in any CIED patient who presents with fever, bloodstream infection, or signs of sepsis, even if the device pocket appears uninfected. Prompt recognition and management may improve outcomes.

KW - endocarditis

KW - implantable cardioverter-defibrillator

KW - permanent pacemaker

UR - http://www.scopus.com/inward/record.url?scp=84856979700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856979700&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2011.11.011

DO - 10.1016/j.jacc.2011.11.011

M3 - Article

C2 - 22322085

AN - SCOPUS:84856979700

VL - 59

SP - 681

EP - 687

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 7

ER -